| Name | (2R,3R,4S,5R)-2-[6-[[(1R)-2,3-dihydro-1H-inden-1-yl]amino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol |
|---|---|
| Synonyms |
Adenosine, N-[(1R)-2,3-dihydro-1H-inden-1-yl]
PD 117519, 10 mM in DMSO PD 117519 (CI947) N-[(1R)-2,3-Dihydro-1H-inden-1-yl]adenosine N-[(1R)-2,3-Dihydro-1H-inden-1-yl]-adenosine PD-117519;PD 117519;PD117519;CI 947;CI N6-[1-(R)-indanyl]adenosine PD 117519,R N-[(R)-Indan-1-yl]adenosine, PD-117519, CI947 (R)-N-(2,3-dihydro-1H-inden-1-yl) adenosine CI-947,PD-117519,Adenosine Rector,Inhibitor,P1 rector,PD117519,PD 117519,inhibit,CI N-[[(R)-2,3-Dihydro-1H-inden]-1α-yl]adenosine (R)-N-(2,3-Dihydro-1H-indenyl)adenosine (2R,3R,4S,5R)-2-(6-(((R)-2,3-Dihydro-1H-inden-1-yl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol N-[(R)-Indan-1-yl] adenosine, Drug, N-substituted adenosine rector agonist, a potential antihypertensive agent N-[(1R)-Indan-1-yl]adenosine N-[(R)-Indan-1-yl]adenosine |
| Description | PD 117519 is an adenosine agonist.Target: Adenosine ReceptorPD 117519 is an adenosine agonist which has shown oral antihypertensive activity in pharmacological animal models. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.71g/cm3 |
|---|---|
| Boiling Point | 723.3ºC at 760 mmHg |
| Molecular Formula | C19H21N5O4 |
| Molecular Weight | 383.40100 |
| Flash Point | 391.2ºC |
| Exact Mass | 383.15900 |
| PSA | 125.55000 |
| LogP | 0.61020 |
| Index of Refraction | 1.821 |
| Storage condition | 2-8℃ |
|
~40%
96392-15-3 |
| Literature: Kusachi,Shozo; Thompson, Robert D.; Yamada, Nobuyuki; Daly, Daniel T.; Olsson, R. A. Journal of Medicinal Chemistry, 1986 , vol. 29, # 6 p. 989 - 996 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |